In the context of rapid technological development such as hybrid closed loop insulin pumps [54, 55] and an increasing prevalence of T1DM [1, 56, 57], equity may play an increasingly important role in the future of outcomes in childhood T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.